Septerna discontinues SEP-786 Phase 1 clinical trial in hypoparathyroidism
Septerna (SEPN) announced its decision to discontinue the Phase 1 single- and multiple-ascending dose clinical trial of SEP-786 in healthy ...
Septerna Announces Discontinuation of SEP-786 Phase 1 Clinical Trial and Plans to Advance Next-Generation Oral Small Molecule PTH1R Agonist
Trial decision follows unanticipated events of elevated unconjugated bilirubin levels Company advancing multiple next-generation PTH1R agonists with distinct and unrelated chemical structures relative ...
Dear Annie: Sister’s irritability could hint at bigger, but solvable, problem
Dear Annie: I just read your column about the woman whose sister-in-law has become exceedingly short-tempered and abusive, ...
MLive3d
Dear Annie: I think short-tempered woman described by reader really needs a medical check-up
Dear Another Alternative: Your story is a great reminder that we can never be sure of the battles someone else is facing or ...
Dear Annie: A benign tumor caused me to be mean as a snake
There can be many symptoms of a faulty parathyroid, but my main symptom was that I was mean as a snake! I had the one ...
Daily4d
Parathyroidectomy Tied to Early Improvement in Inflammatory and Cardiovascular Risk Factors in PHPT: Study
Turkey: A recent retrospective study explored the effects of parathyroidectomy (PTX) on inflammatory and cardiovascular risk ...
Too Old to Operate6d
Q&A: How Physicians Can Prevent Complications in Hypoparathyroidism Management, Part 1
Drawing from personal experience, Patty Keating advocates for greater awareness, improved diagnosis, and treatment among ...